The relationship between Feno and effectiveness of mepolizumab and benralizumab in severe eosinophilic asthma
A Hearn, Joanne Kavanagh, G d’Ancona, Cris Roxas, Linda Green, Louise Thomson, Marianna Fernandes, Brian D. Kent, Jaideep Dhariwal, Alexanda M. Nanzer, David J. Jackson
Topics & Concepts
MepolizumabBenralizumabExacerbationMedicineEosinophilicAsthmaImmunologyMonoclonal antibodyPathogenesisMonoclonalEosinophilAntibodyPathologyAsthma and respiratory diseasesEosinophilic EsophagitisIL-33, ST2, and ILC Pathways